Kewaunee Scientific (KEQU) EBT (2010 - 2026)

Kewaunee Scientific's EBT history runs 17 years deep, the most recent figure standing at $4.8 million for Q2 2026.

• On a quarterly basis, EBT fell 33.47% year-over-year to $4.8 million in Q2 2026; TTM through Apr 2026 was $13.7 million, a 7.12% decrease from a year earlier, with the FY2026 full-year figure at $13.7 million, down 7.12% from the prior year.
• EBT rose to $4.8 million in Q2 2026 per KEQU's latest filing, from $1.6 million in the prior quarter.
• Across five years, EBT topped out at $7.1 million in Q2 2025 and bottomed at -$887000.0 in Q1 2022.
• The 5-year median for EBT is $2.4 million (2022), against an average of $2.6 million.
• Across the five-year window, EBT jumped 1103.53% in 2023 and tumbled 63.73% in 2025, its largest moves.
• Year by year, EBT stood at $456000.0 in 2022, then surged by 962.5% to $4.8 million in 2023, then slipped by 18.86% to $3.9 million in 2024, then slipped by 12.16% to $3.5 million in 2025, then jumped by 37.74% to $4.8 million in 2026.
• Per Business Quant, the three latest KEQU EBT figures stand at $4.8 million (Q2 2026), $1.6 million (Q1 2026), and $3.5 million (Q4 2025).